Stock comparison

VTRSvsZTS

Viatris IncvsZoetis Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

VTRS

Viatris Inc

$14.75

+26.61%

Pharmaceuticals$15.6BNASDAQ
ZTS

Zoetis Inc

$116.06

-2.19%

Pharmaceuticals$48.8BNYSE

60-day price, rebased to 100

VTRS +13.72% · ZTS -4.81%

Round-by-round

VTRS 2·ZTS 4
EdgeVTRS

Valuation upside

+97.70% vs -36.20% to DCF fair value

EdgeZTS

Balance-sheet strength

Altman Z 0.89 vs 5.39

EdgeZTS

Fundamental quality

Piotroski 4.00 vs 6.00 (of 9)

EdgeZTS

Growth + margins

Rule-of-40 10.00 vs 26.40

EdgeVTRS

60-day momentum

+13.72% vs -4.81% price return

EdgeZTS

Market-cap liquidity

$15.6B vs $48.8B

Verdict

Across6categories,ZTStakes the edge with4wins to2. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onVTRSorZTS

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.

For informational and educational purposes only. Not financial advice. Learn more